BH3 mimetics reactivate autophagic cell death in anoxia-resistant malignant glioma cells

Neoplasia. 2008 Aug;10(8):873-85. doi: 10.1593/neo.07842.

Abstract

Here, we investigated the specific roles of Bcl-2 family members in anoxia tolerance of malignant glioma. Flow cytometry analysis of cell death in 17 glioma cell lines revealed drastic differences in their sensitivity to oxygen withdrawal (<0.1% O(2)). Cell death correlated with mitochondrial depolarization, cytochrome C release, and translocation of green fluorescent protein (GFP)-tagged light chain 3 to autophagosomes but occurred in the absence of caspase activation or phosphatidylserine exposure. In both sensitive and tolerant glioma cell lines, anoxia caused a significant up-regulation of BH3-only genes previously implicated in mediating anoxic cell death in other cell types (BNIP3, NIX, PUMA, and Noxa). In contrast, we detected a strong correlation between anoxia resistance and high expression levels of antiapoptotic Bcl-2 family proteins Bcl-xL, Bcl-2, and Mcl-1 that function to neutralize the proapoptotic activity of BH3-only proteins. Importantly, inhibition of both Bcl-2 and Bcl-xL with the small-molecule BH3 mimetics HA14-1 and BH3I-2' and by RNA interference reactivated anoxia-induced autophagic cell death in previously resistant glioma cells. Our data suggest that endogenous BH3-only protein induction may not be able to compensate for the high expression of antiapoptotic Bcl-2 family proteins in anoxia-resistant astrocytomas. They also support the conjecture that BH3 mimetics may represent an exciting new approach for the treatment of malignant glioma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzamides / pharmacology*
  • Benzopyrans / pharmacology*
  • Biomimetic Materials / pharmacology*
  • Caspases / metabolism
  • Cell Death / drug effects
  • Cell Hypoxia / drug effects
  • Drug Resistance, Neoplasm
  • Flow Cytometry
  • Glioma / drug therapy
  • Glioma / metabolism*
  • Glioma / pathology
  • Humans
  • Membrane Potential, Mitochondrial
  • Microscopy, Fluorescence
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Nitriles / pharmacology*
  • Proto-Oncogene Proteins c-bcl-2 / drug effects
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • RNA Interference / drug effects
  • RNA, Small Interfering / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensitivity and Specificity
  • Tumor Cells, Cultured
  • Up-Regulation / drug effects
  • bcl-2-Associated X Protein / drug effects
  • bcl-2-Associated X Protein / metabolism
  • bcl-X Protein / drug effects
  • bcl-X Protein / metabolism

Substances

  • 3-iodo-5-chloro-N-(2-chloro-5-((4-chlorophenyl)sulphonyl)phenyl)-2-hydroxybenzamide
  • BAX protein, human
  • BCL2L1 protein, human
  • Benzamides
  • Benzopyrans
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Nitriles
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Small Interfering
  • bcl-2-Associated X Protein
  • bcl-X Protein
  • ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
  • Caspases